The shareholders of Cellectis (ENXTPA:ALCLS) authorized a share repurchase program at its Combined General Shareholders' Meeting on June 14, 2013. Under the program, the company will repurchase its own shares.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.706 EUR | +0.71% | +0.95% | -38.28% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.28% | 132M | |
+18.09% | 44.48B | |
+44.19% | 40.57B | |
-8.38% | 38.82B | |
+34.66% | 32.22B | |
-8.34% | 27.84B | |
+16.10% | 26.79B | |
+49.73% | 14.31B | |
+36.71% | 12.7B | |
-6.60% | 11.23B |
- Stock Market
- Equities
- ALCLS Stock
- News Cellectis S.A.
- Cellectis announces an Equity Buyback.